ABVC - Company ID 0001173313
ABVC BIOPHARMA, INC. has filed 780 public company documents between 2002 and 2026. The most frequent type is major company event (250 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 10-Q | Quarterly report | 1mo ago2026-05-18 | 2026-03-31 | View filing |
| NT 10-Q | NT 10-Q | 1mo ago2026-05-15 | 2026-03-31 | View filing |
| POS AM | POS AM | 3mo ago2026-03-27 | - | View filing |
| 8-K | Major company event | 3mo ago2026-03-27 | 2026-03-27 | View filing |
| DEF 14A | Proxy statement | 4mo ago2026-03-05 | 2026-03-26 | View filing |
| 10-K | Annual report | 4mo ago2026-03-03 | 2025-12-31 | View filing |
| 10-Q/A | Quarterly report (amended) | 4mo ago2026-03-03 | 2025-09-30 | View filing |
| 8-K | Major company event | 4mo ago2026-03-03 | 2026-03-03 | View filing |
| PRE 14A | PRE 14A | 5mo ago2026-02-05 | 2026-02-05 | View filing |
| 8-K/A | Major company event (amended) | 5mo ago2026-01-16 | 2025-04-30 | View filing |
| 424B4 | 424B4 | 7mo ago2025-11-14 | - | View filing |
| 424B4 | 424B4 | 7mo ago2025-11-14 | - | View filing |
| 424B4 | 424B4 | 7mo ago2025-11-14 | - | View filing |
| 424B4 | 424B4 | 7mo ago2025-11-14 | - | View filing |
| 8-K | Major company event | 8mo ago2025-11-03 | 2025-11-03 | View filing |
| 10-Q | Quarterly report | 8mo ago2025-11-03 | 2025-09-30 | View filing |
| 8-K | Major company event | 8mo ago2025-10-30 | 2025-10-28 | View filing |
| 8-K/A | Major company event (amended) | 10mo ago2025-09-12 | 2024-10-18 | View filing |
| 424B4 | 424B4 | 10mo ago2025-08-15 | - | View filing |
| 424B4 | 424B4 | 10mo ago2025-08-15 | - | View filing |
| 424B4 | 424B4 | 10mo ago2025-08-15 | - | View filing |
| 424B4 | 424B4 | 10mo ago2025-08-15 | - | View filing |
| 424B4 | 424B4 | 10mo ago2025-08-15 | - | View filing |
| 8-K | Major company event | 10mo ago2025-08-14 | 2025-08-14 | View filing |
| 10-Q | Quarterly report | 11mo ago2025-08-13 | 2025-06-30 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 11mo ago2025-08-13 | - | View filing |
| 8-K/A | Major company event (amended) | 11mo ago2025-07-18 | 2024-02-08 | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 11mo ago2025-07-15 | - | View filing |
| S-8 | Employee stock plan | 1y ago2025-06-27 | - | View filing |
| 8-K | Major company event | 1y ago2025-06-04 | 2025-06-03 | View filing |
| SCHEDULE 13D | SCHEDULE 13D | 1y ago2025-06-03 | - | View filing |
| 8-K/A | Major company event (amended) | 1y ago2025-05-30 | 2025-04-30 | View filing |
| POS AM | POS AM | 1y ago2025-05-27 | - | View filing |
| POS AM | POS AM | 1y ago2025-05-27 | - | View filing |
| POS AM | POS AM | 1y ago2025-05-27 | - | View filing |
| S-3 | Securities registration | 1y ago2025-05-22 | - | View filing |
| EFFECT | EFFECT | 1y ago2025-05-20 | - | View filing |
| EFFECT | EFFECT | 1y ago2025-05-20 | - | View filing |
| DEF 14A | Proxy statement | 1y ago2025-05-16 | 2025-06-03 | View filing |
| POS AM | POS AM | 1y ago2025-05-16 | - | View filing |
| POS AM | POS AM | 1y ago2025-05-16 | - | View filing |
| 8-K/A | Major company event (amended) | 1y ago2025-05-14 | 2025-04-30 | View filing |
| 8-K/A | Major company event (amended) | 1y ago2025-05-14 | 2024-07-12 | View filing |
| 8-K/A | Major company event (amended) | 1y ago2025-05-06 | 2025-04-30 | View filing |
| 8-K/A | Major company event (amended) | 1y ago2025-05-02 | 2025-04-15 | View filing |
| 8-K | Major company event | 1y ago2025-05-01 | 2025-05-01 | View filing |
| 10-Q | Quarterly report | 1y ago2025-04-30 | 2025-03-31 | View filing |
| 8-K | Major company event | 1y ago2025-04-30 | 2025-04-30 | View filing |
| PRE 14A | PRE 14A | 1y ago2025-04-25 | 2025-04-24 | View filing |
| 8-K/A | Major company event (amended) | 1y ago2025-04-16 | 2025-04-15 | View filing |